PTAB Designates as Informative Three Decisions on Obviousness and Patent Eligibility

Dec 31, 2019

Reading Time : 4 min

Hulu, LLC v. Sound View Innovations, LLC, Case IPR2018-00582, Paper 34 (Aug. 5, 2019).

In Hulu, the claims were directed to the real-time processing of events generated by an application, such as fraud detection in a telecommunications network, comprising a real-time processor and main-memory database. Petitioner argued that the primary reference, O’Neil, disclosed a real-time processor and a database, and that it would have been obvious to upgrade the database to a main-memory database taught in the secondary references, Kao and Dewitt. According to Petitioner, a person of skill would have been motivated to combine the references based on the “tight timing requirements” in O’Neil’s real-time call monitoring system.

Citing evidence from O’Neil and its expert, Patent Owner argued that Petitioner’s reasoning was inadequate because the “tight timing requirements” in O’Neil’s system did not warrant the use of a main-memory database. The Board agreed and highlighted uncontested expert testimony that the “vast majority” of database systems at the time of the patent were conventional disk-resident database systems, which had adequate timing for O’Neil’s purposes. The Board also noted disadvantages of main-memory databases, such as cost, limited capacity and volatility, which undermine the combination in the absence of other persuasive reasons to modify O’Neil.

Practice Tip: A generalized desire for improvement may not be sufficient motivation to combine if the improvement could already have been achieved by conventional means at the time of the invention, particularly when there are disadvantages to the proffered combination. The obviousness analysis is fact-specific and should be supported by documentary evidence and reasoned expert testimony.

Johns Manville Corp. v. Knauf Insulation, Inc., IPR 2018-00827, Paper 9 (Oct. 16, 2018).

In Johns Manville, the claims were directed to insulation material comprising glass fibers and a certain binder. Petitioner argued that a combination based on two references, Srinivasan and Worthington, was obvious because they were analogous and disclose binders containing “reactants in similar endeavors related to each other.” The Board rejected Petitioner’s reasoning because demonstrating that references are analogous art, relevant to the field of endeavor of the challenged patent and compatible is not sufficient to establish a reason to combine.

Petitioner also argued that Srinivasan teaches methods lending themselves to the use of certain binder compositions, and Worthington expressly teaches that its methods are appropriate for those compositions. The Board, however, found that Petitioner’s argument did not compare the binder in Worthington to the binder in Srinivasan and did not give a reason to substitute Worthington’s binder for the one in Srinivasan. The Board noted evidence in the references that the binders in each reference were “considerably different” and that Petitioner and its expert did not sufficiently explain and cite evidence for why the combination would have been predictable.

Practice Tip: To show a reason to combine and a reasonable expectation of success, Petitioners should provide explanation and evidence specific to the proffered combination required to achieve the claimed invention—mere compatibility of the references is insufficient. Also, bare assertions that a combination would have been predictable is entitled to little weight.

Ex Parte Linden, 2018-003323 (Apr. 1, 2019).

In Ex Parte Linden, the claims recited a computer-implemented method for transcribing speech. The Examiner found that the claims were directed to the abstract idea of “using the predicted character probabilities (mathematical formula) to decode a transcription of the input audio into words or text data.” Applying prong one of step 2A of the USPTO’s 2019 guidance on patent eligibility, the Examiner categorized the abstract idea under mathematical formulae, organizing human activity and mental processes because a human can transcribe the audio data.

The Board disagreed the claims recite a mental process. According to the Board, the claims recite steps that cannot be performed by a human, e.g., normalizing an input file, generating a jitter set of audio files, generating a set of spectrogram frames, obtaining predicted character probabilities from a trained neural network and decoding a transcription of the input audio using the predicted character probability outputs. The Board also disagreed that the claims recite organizing human activity because they do not include fundamental economic principles, commercial or legal interactions, or managing personal behavior or relationships or interactions between people.

The Board also found that the claims do not recite a mathematical algorithm. The claims recite using predicted character probabilities to decide a transcription of the input audio, and the specification describes an algorithm to obtain those probabilities. The claims, however, do not recite the described algorithm. Applying prong 2 of step 2A of the USPTO’s 2019 guidance, the Board reasoned that even if the claims recited a mathematical concept, the claims themselves are not directed to an abstract idea because the alleged abstract idea is integrated into a practical application—namely, the claims “include specific features that were specific designed to achieve an improved technological result” and “provide improvements to a technical field.”

Practice Tip: In prosecution, patent applicants should draft claims to avoid the list of abstract ideas in the USPTO’s 2019 guidance, e.g., methods organizing human activity and mental processes. Also avoid reciting mathematical concepts, but to the extent the claims do so, draft the claims to also include specific features designed to achieve an improved technological result, such as the trained neural network and improved language model in Ex Parte Linden.

Share This Insight

Previous Entries

IP Newsflash

October 1, 2025

In a recent final written decision, the PTAB determined that a reference patent was not prior art, despite the petitioner’s post‑filing attempt to correct its petition. While the petitioner argued that it intended to rely on the patent application’s earlier date of publication, both the corrected petition and the expert declaration continued to reference the issued patent rather than the published application.

...

Read More

IP Newsflash

September 30, 2025

The USPTO Director recently granted a petitioner’s request for rehearing of the decision discretionarily denying institution of inter partes review, ultimately vacating the original decision, and referring the petition to the board for an institution decision.

...

Read More

IP Newsflash

September 25, 2025

In considering claims to a method of reducing cardiovascular events, the Federal Circuit held that the term a “clinically proven effective” amount did not render the claims patentable over the prior art. Specifically, the Federal Circuit held that the “clinically proven effective” amount, whether limiting or not, could not be used to distinguish the prior art because the claims also specified the exact amount of the drugs to be administered in the method. The Federal Circuit also rejected patentee’s evidence of unexpected results because that evidence was tied solely to the “clinically proven effective” limitation.

...

Read More

IP Newsflash

September 24, 2025

The Federal Circuit reversed a district court’s denial of judgment as a matter of law on non-infringement, thereby setting aside a $106 million jury verdict, after holding that prosecution history estoppel barred the patentee from asserting infringement under the doctrine of equivalents.

...

Read More

IP Newsflash

September 17, 2025

A magistrate judge in the District of Delaware issued a Report and Recommendation, that found the sole asserted claim was a “single means” claim and therefore invalid for lack of enablement. In reaching that conclusion, the magistrate judge rejected the patentee’s argument that the preamble of the claim disclosed a second element that satisfied the combination requirement of Section 112, paragraph 6 because the preamble simply recited a descriptor of the very apparatus that was the subject of the means-plus-function limitation in the body of the claim. The district court judge presiding over this case has scheduled a hearing to review the magistrate’s ruling.

...

Read More

IP Newsflash

September 9, 2025

The Federal Circuit has affirmed the PTAB’s determination that a patent challenger did not show the challenged claims were unpatentable for obviousness. The Federal Circuit concluded that substantial evidence, which included expert testimony, showed there was no motivation to combine the references.

...

Read More

IP Newsflash

August 29, 2025

In a recent order addressing four IPR proceedings, the PTAB exercised its inherent authority under 37 C.F.R. § 42.5(a) to sua sponte authorize post-hearing discovery on a potentially dispositive privity issue. The order followed a Director review decision that vacated and remanded earlier IPRs involving the same parties, patent family, and privity issue. 

...

Read More

IP Newsflash

August 29, 2025

The Patent Trial and Appeal Board denied institution of an inter partes review petition in part because it determined that a patent reference was not prior art under the common ownership exception of pre-AIA 35 U.S.C. § 103(c)(1).

...

Read More

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.